Nuzenio

Lexeo Therapeutics Inc

Lexeo Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of "Buy" from Brokerages - MarketBeatMarketBeat · Mon, 10 Aug 2026 08:33:05 GMT Lexeo Therapeutics Inc (LXEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 17:26:18 GMT Lexeo Therapeutics (LXEO) Projected to Release Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:12:14 GMT Lexeo wins FDA RMAT designation for LX2020 in PKP2 arrhythmogenic cardiomyopathy - BitgetBitget · Wed, 05 Aug 2026 19:40:53 GMT Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 11:00:00 GMT Lexeo's heart gene therapy gets FDA status after interim data - stocktitan.netstocktitan.net · Wed, 05 Aug 2026 11:00:00 GMT Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For LX2020 For The Treatment Of PKP2 Arrhythmogenic Cardiomyopathy - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 11:00:00 GMT Lexeo Therapeutics, Inc. $LXEO Shares Sold by Janus Henderson Group PLC - MarketBeatMarketBeat · Mon, 03 Aug 2026 10:10:21 GMT

Timeline

Mon, 10 Aug 2026 08:33:05 GMTLexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Fri, 07 Aug 2026 17:26:18 GMTLexeo Therapeutics Inc (LXEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Thu, 06 Aug 2026 08:12:14 GMTLexeo Therapeutics (LXEO) Projected to Release Earnings on Thursday - MarketBeat

Wed, 05 Aug 2026 19:40:53 GMTLexeo wins FDA RMAT designation for LX2020 in PKP2 arrhythmogenic cardiomyopathy - Bitget

Wed, 05 Aug 2026 11:00:00 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - Yahoo Finance

Wed, 05 Aug 2026 11:00:00 GMTLexeo's heart gene therapy gets FDA status after interim data - stocktitan.net

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

LXEO12 live mentions Inc8 live mentions TradingKey Lexeo Therapeutics4 live mentions Lexeo Therapeutics3 live mentions MarketBeat Lexeo Therapeutics3 live mentions Lexeo3 live mentions Lexeo Therapeutics Receives3 live mentions FDA Regenerative Medicine3 live mentions Arrhythmogenic Cardiomyopathy3 live mentions NASDAQ2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lexeo Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.